Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial.

Conclusions: Rivaroxaban is effective and safe for the treatment of VTE in patients with active cancer.
PMID: 29788694 [PubMed - as supplied by publisher]

Source: The Korean Journal of Internal Medicine - May 23, 2018 Category: Internal Medicine Authors: Yhim HY, Choi WI, Kim SH, Nam SH, Kim KH, Mun YC, Oh D, Hwang HG, Lee KW, Song EK, Kwon YS, Bang SM Tags: Korean J Intern Med Source Type: research